top of page

Dexcom G7, in collaboration with Lincoln Health Supply, is poised to revolutionize CGM technology

The Dexcom G7 is the next generation of CGM technology, offering significant improvements over its predecessor, the Dexcom G6. One of the standout features of the G7 is its smaller, more discreet design, making it less obtrusive and more comfortable for users. The G7 sensor is also disposable, eliminating the need for regular sensor insertions and replacements.


With the Dexcom G7, users can expect enhanced accuracy in glucose readings, enabling them to make precise treatment decisions. The device utilizes advanced algorithms and sensor technology to provide reliable glucose measurements, reducing the likelihood of false alarms and ensuring more accurate data.


The Dexcom G7 prioritizes user-friendliness, making it accessible to a wide range of individuals managing diabetes. The device features an intuitive touchscreen interface that simplifies navigation and data interpretation. Additionally, the G7 seamlessly integrates with smartphones and smartwatches, allowing users to monitor their glucose levels on the go using the Dexcom mobile app.


Collaboration with Lincoln Health Supply NBV:

Lincoln Health Supply NBV, a trusted distributor of medical supplies ranking within the top 10 nationwide, has partnered with Dexcom to ensure widespread availability and distribution of the G7. This collaboration aims to streamline the procurement process, making the G7 readily accessible to healthcare providers and patients, thereby improving diabetes management worldwide.


The Dexcom G7's advanced features and improved accuracy offer numerous benefits for individuals managing diabetes. By providing real-time glucose data, the G7 enables users to proactively respond to fluctuations and avoid potential complications. It also facilitates better communication between patients and healthcare professionals, allowing for customized treatment plans and improved overall management of the condition.


The Dexcom G7, in collaboration with Lincoln Health Supply NBV, represents a significant advancement in CGM technology. Through its smaller design, enhanced accuracy, and user-friendly features, the G7 empowers individuals with diabetes to take control of their health. With the continuous evolution of CGM technology, the future holds promising possibilities for improved diabetes management and enhanced quality of life for millions of people worldwide. To learn more about Dexcom G7's release plans on their newest CGM system for non-insulin Type 2 diabetic patients, click here.

コメント


bottom of page